CMS launches interoperability database

CMS has announced the launch of the Data Element Library (DEL)—databaste for supporting the exchange of electronic health information.

The free, centralized data base gives users a view on specific types of data CMS requires from post-acute care facilities to collect as part of the health assessment of patients. The assessments available include data on demographics, medical problems and other types of health evaluations. Healthcare facilities integrate this patient data into their electronic records systems to be used for payment by CMS, quality measurement and quality improvement.

The DEL also includes health information technology standards that support the collection of health information. The comprehensive database services as a one-stop shop for health IT vendors to incorporate data elements into electronic health records used by post-acute care providers. This integration allows for improved interoperability between one provider to another.

“We’re excited to add this important building block to the foundation for interoperability that CMS is helping to establish,” said CMS Administrator Seema Verma. “The DEL supports the use and sharing of data, and aligns with MyHealthEData, a governmentwide effort strengthening the interoperability of health information. It also closely aligns with CMS’s Patients Over Paperwork initiative focused on reducing administrative burden and costs while improving care coordination, outcomes and patients’ ability to make decisions about their own care.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.